---

Frusemide-induced acute pancreatitis: Report of a rare case

Full Text PDF Share on Facebook Share on Twitter

---

Case Report

Author Details : Sumaira Kanwal Rafiqui*, Mohamed Elmudathir Osman

Volume : 3, Issue : 2, Year : 2024

Article Page : 163-165

https://doi.org/10.18231/j.yjom.2024.015

Suggest article by email

Abstract

This paper reported a rare case of frusemide-induced acute pancreatitis in a 65-year-old female who presented to the emergency department with severe epigastric pain and vomiting for two days. Her medical history included type 2 diabetes mellitus and liver cirrhosis caused by hepatitis C virus infection, for which she was taking insulin and spironolactone. Ten days prior, she was prescribed frusemide for poorly controlled ascites. She had no history of alcoholism or gallbladder disease. However, two years ago, the patient developed acute pancreatitis. Upon reviewing her medical record, we found that her first acute pancreatitis episode occurred after she had been prescribed frusemide 40 mg daily for ascites control six days before the pancreatitis episode. Serum amylase was 1022 IU/L, and lipase was 3122 IU/L, while abdominal ultrasonography showed a contracted gallbladder without lithiasis and a normal biliary tree and liver. The patient was diagnosed with frusemide-induced acute pancreatitis. She received conservative management with analgesia, hydration, and fasting. Abdominal paracentesis was performed with an albumin replacement. In the following days, the patient remained stable and afebrile, and her symptoms improved. Consequently, she was discharged with strict instructions to avoid frusemide in the future.

Keywords: Frusemide, Acute pancreatitis, Rechallenge, Liver cirrhosis 1

How to cite : Rafiqui S K, Osman M E, Frusemide-induced acute pancreatitis: Report of a rare case. Yemen J Med 2024;3(2):163-165

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International, which allows others to remix, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.